Stock Exchange Releases

3/1/2023 Orion Corporation: Transfer of 149,798 own B shares on 1 March 2023 
2/28/2023 Orion Group Financial Statement documents 2022, Corporate Governance Statement and Remuneration Report published
2/9/2023 Notice to the Annual General Meeting of Orion Corporation
2/9/2023 Orion Group Financial Statement Release 2022

Read the latest articles

Material Bank

Press Releases

3/20/2023 Darolutamide approved for additional prostate cancer indication in China
3/1/2023 Darolutamide receives EU approval for additional indication in prostate cancer
2/27/2023 Darolutamide receives approval for additional prostate cancer indication in Japan
2/9/2023 Save the date: Orion’s Capital Markets Day 2023

Disclosure Policy

The key principles in Orion’s communications are openness, impartiality, reliability, simultaneousness and consistency.

Read more
Orion's century
About Orion
Products and Services
Investors
Media
Corporate Governance
AGM
Contact us